ID,MEDICATION,GENE(S),PRESCRIBING CONSIDERATIONS BASED ON myDNA TEST,INTERACTION
N24-325,Duloxetine,"CYP1A2CYP2D6","Minor – result should be considered as may affect medicationresponse",INHIBITOR MODERATE: CYP2D6
N24-325,Pantoprazole,CYP2C19,"Minor – result should be considered as may affect medicationresponse",NA
N24-325,Codeine (component of Acetaminophen-Caffeine-Codeine),"CYP2D6OPRM1",Usual prescribing considerations apply,NA
N24-325,oestrogen (Premarin Tablets),NA,NO,NA
N24-325, trazadone,NA,NO,NA
N24-325, clobetasol propionate (Penta-Clobetasol Cream),NA,NO,NA
N24-325, acetaminophen (component of Acetaminophen-Caffeine-Codeine),NA,NO,NA
N24-325, caffeine (component of Acetaminophen-Caffeine-Codeine),NA,NO,NA
